课题基金 / 基金详情

Neuro Modulated Diabetes Control (NeuMeDic): Decoding the brain and neural pathways to achieve a better control of diabetes

Neuro Modulated Diabetes Control (NeuMeDic): Decoding the brain and neural pathways to achieve a better control of diabetes
神经调节糖尿病控制 (NeuMeDic):解码大脑和神经通路以更好地控制糖尿病
批准号:
2029368
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
糖尿病是一种由葡萄糖代谢过程中的故障引起的疾病,导致血糖异常波动。传统上,控制涉及响应于升高的血糖的外部胰岛素注射,以替代胰腺中的β细胞的作用,否则胰腺将在健康个体中执行该功能。然而,中枢神经系统(CNS)通过控制胰腺分泌和胰岛素敏感性在葡萄糖稳态中也起着至关重要的作用,这可能被用作增强葡萄糖控制的途径。在这种情况下,一个新的新兴领域称为生物电子医学,它依赖于对器官神经信号的电调制,已被引入作为使用药物的替代治疗。进一步推进这一新兴领域,这个博士项目旨在研究通过生物电子医学与神经通路接口是否有潜在的好处,以获得更严格的控制糖尿病患者的血糖水平。更详细地说,这个博士项目旨在:i)了解在体内健康和糖尿病状态下这种神经调节的生理基础(特别是在用餐期间),ii)首次研究在体内调节这些神经信号用于糖尿病管理的潜在益处,以及iii)开发要包括在现有的健康和糖尿病模拟器中的新型数学模型。这种新的糖尿病管理方法将对糖尿病患者的生活质量产生重大影响。它将允许糖尿病患者自动保持更好的血糖控制,从而减少因其失调而产生的并发症。它还将通过减少与这种疾病相关的医疗费用(2012年美国为2450亿美元)来影响医疗保健服务。因此,拟议的博士学位将在神经技术和糖尿病领域做出重大科学贡献。该博士学位与几个EPSRC研究领域保持一致,包括数学生物学和工程设计。
英文摘要
Diabetes is a disease caused by a breakdown in the glucose metabolic process resulting in abnormal blood glucose fluctuations. Traditionally, control has involved external insulin injection in response to elevated blood glucose to substitute the role of the beta cells in the pancreas, which would otherwise perform this function in a healthy individual. The central nervous system (CNS), however, also plays a vital role in glucose homoeostasis through the control of pancreatic secretion and insulin sensitivity which could potentially be used as a pathway for enhancing glucose control. Within this context, a novel emerging field called bioelectronic medicine, which relies on electrical modulation of the neural signals to the organs, has been introduced as an alternative treatment to using pharmaceuticals. Furthering this new emerging field, this PhD project aims at studying whether there is potential benefit of interfacing with the neural pathways through bioelectronic medicine for acquiring a tighter control of glucose levels in people with diabetes.In more detail, this PhD project aims at: i) understanding the physiological basis that underlie this neural regulation in the healthy and diabetic states in vivo (particularly during meals), ii) studying for the first time the potential benefits of modulating these neural signals in vivo for diabetes management and iii) developing novel mathematical models to be included in existing healthy and diabetes simulators. This new approach for diabetes management will have a great impact on the diabetic patients' quality of life. It will allow diabetic people to automatically maintain a better glucose control, leading to a reduction of the complications derived from its deregulation. It will also impact health care services by reducing the medical costs associated with this disease ($245 billion in US in 2012).Therefore, the proposed PhD will lead to major scientific contributions in the fields of Neurotechnology and Diabetes. This PhD is in alignment with several EPSRC research areas, including Mathematical Biology and Engineering Design.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s42234-018-0009-4
发表时间: 2018-01-01
期刊: Bioelectronic medicine
影响因子: --
作者: [Guemes, Amparo, Georgiou, Pantelis]
通讯作者: Georgiou, Pantelis
A Novel Glucose Controller using Insulin Sensitivity Modulation for Management of Type 1 Diabetes
使用胰岛素敏感性调节的新型血糖控制器用于治疗 1 型糖尿病
DOI: 10.1109/iscas.2019.8702535
发表时间: 2019
期刊:
影响因子: --
作者: [Guemes A]
通讯作者: Guemes A
DOI: 10.1186/s42234-020-00046-4
发表时间: 2020-01-01
期刊: Bioelectronic medicine
影响因子: --
作者: [Guemes Gonzalez, Amparo, Etienne-Cummings, Ralph, Georgiou, Pantelis]
通讯作者: Georgiou, Pantelis
A controller for blood glucose regulation based on modulation of insulin sensitivity in people with type 1 diabetes
基于 1 型糖尿病患者胰岛素敏感性调节的血糖调节控制器
DOI: --
发表时间: 2019
期刊:
影响因子: --
作者: [Güemes A]
通讯作者: Güemes A
海外基金